Itron (NASDAQ:ITRI) Given New $105.00 Price Target at BNP Paribas Exane

Itron (NASDAQ:ITRI) had its price target cut by equities research analysts at BNP Paribas Exane from $115.00 to $105.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has an “outperform” rating on the scientific and technical instruments company’s stock. BNP Paribas Exane‘s target price suggests a potential upside of 11.05% from the stock’s current price.

ITRI has been the subject of several other research reports. Robert W. Baird set a $125.00 price target on Itron in a research note on Wednesday, July 29th. Needham & Company LLC increased their price objective on shares of Itron from $116.00 to $128.00 and gave the company a “buy” rating in a research note on Wednesday, July 29th. Weiss Ratings upgraded shares of Itron from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, October 12th. Seaport Research Partners restated a “buy” rating and set a $150.00 target price on shares of Itron in a research report on Wednesday, July 29th. Finally, Oppenheimer reaffirmed an “outperform” rating on shares of Itron in a report on Wednesday. Nine research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Itron currently has an average rating of “Moderate Buy” and a consensus target price of $129.60.

Itron Trading Up 7.8%

Shares of ITRI opened at $94.55 on Wednesday. The company has a 50-day simple moving average of $91.26 and a 200-day simple moving average of $91.10. Itron has a 52-week low of $77.77 and a 52-week high of $142.00.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, October 27th. The scientific and technical instruments company reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.56 by $0.38. The company had revenue of $599.33 million for the quarter, compared to analysts’ expectations of $595.50 million. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.54 EPS. As a group, research analysts anticipate that Itron will post 6.41 EPS for the current year.

Insider Activity

In related news, SVP Justin K. Patrick sold 10,210 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $97.36, for a total transaction of $994,045.60. Following the transaction, the senior vice president owned 22,065 shares of the company’s stock, valued at approximately $2,148,248.40. This represents a 31.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP John Marcolini sold 331 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $98.79, for a total transaction of $32,699.49. Following the sale, the senior vice president owned 12,683 shares in the company, valued at approximately $1,252,953.57. This trade represents a 2.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 17,903 shares of company stock worth $1,753,521. Company insiders own 1.77% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Impact Partnership Wealth LLC lifted its stake in shares of Itron by 4.7% during the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company’s stock worth $239,000 after purchasing an additional 119 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of Itron by 37.9% during the third quarter. Farther Finance Advisors LLC now owns 640 shares of the scientific and technical instruments company’s stock worth $55,000 after purchasing an additional 176 shares during the last quarter. Two Sigma Securities LLC grew its position in shares of Itron by 5.2% in the second quarter. Two Sigma Securities LLC now owns 3,937 shares of the scientific and technical instruments company’s stock valued at $341,000 after purchasing an additional 195 shares during the period. Personal CFO Solutions LLC grew its position in shares of Itron by 8.3% in the first quarter. Personal CFO Solutions LLC now owns 2,727 shares of the scientific and technical instruments company’s stock valued at $244,000 after purchasing an additional 208 shares during the period. Finally, IFP Advisors Inc grew its position in shares of Itron by 38.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the scientific and technical instruments company’s stock valued at $69,000 after purchasing an additional 224 shares during the period. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q3 earnings beat expectations: Itron reported adjusted earnings of $1.94 per share, well above the $1.56 analyst consensus, while revenue of $599.3 million exceeded expectations of $595.5 million. Revenue grew 3% year over year, and earnings increased from $1.54 per share in the prior-year quarter. Itron Third-Quarter Earnings Results
• Positive Sentiment: Recurring revenue and backlog strengthened: Annual recurring revenue rose 25% to $423 million, while total backlog reached $4.3 billion. The company also generated $102 million in operating cash flow and $96 million in free cash flow, supporting the quality of the quarter’s results. Itron Q3 Revenue and Recurring Revenue Report
• Positive Sentiment: Guidance supports the outlook: Itron forecast fourth-quarter revenue of $621 million to $636 million and full-year 2026 revenue of $2.37 billion to $2.385 billion. The strong outlook is reinforcing investor confidence in utility technology and smart-grid demand. Itron Announces Third-Quarter 2026 Financial Results
• Neutral Sentiment: Technical momentum improved: ITRI broke above its 200-day moving average, a potentially bullish technical signal that may attract momentum-focused investors. The stock remains below its 52-week high, however, leaving valuation and follow-through as key considerations. Itron Stock Breaks Above Two-Hundred-Day Moving Average
• Negative Sentiment: Valuation concerns remain: BNP Paribas Exane lowered its price target to $105, signaling more limited upside in the analyst’s view despite the earnings beat. Separately, reported insider activity showed selling by company executives with no purchases during the period, a potential cautionary signal. BNP Paribas Exane Lowers Itron Price Target

About Itron

Itron, Inc is a technology company that provides solutions to utilities and cities for managing electricity, natural gas, and water resources. Its offerings help organizations measure consumption, collect and analyze data, improve operational efficiency, and support more reliable and sustainable delivery of essential services.

The company’s portfolio includes smart meters, advanced metering infrastructure, communications networks, sensors, data management systems, and utility software.